Skip to main content
Clinical Trials/CTRI/2022/09/045719
CTRI/2022/09/045719
Not yet recruiting
未知

Evaluation of Indocyanine Green for sentinel lymph node biopsy in breast cancer: Two arm, Open label, Parallel design, Non-inferiority, Randomised control trial

Department of Surgical Disciplines0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: C509- Malignant neoplasm of breast of unspecified siteHealth Condition 2: C509- Malignant neoplasm of breast of unspecified site
Sponsor
Department of Surgical Disciplines
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Department of Surgical Disciplines

Eligibility Criteria

Inclusion Criteria

  • Upfront operable primary breast cancer measuring upto and including 5cm in maximum tumour dimension with clinically lymph node negative breast cancers (Tis, T1,T2\-N0\) undergoing upfront surgery
  • Consenting patient

Exclusion Criteria

  • Pregnant or lactating women
  • Patients who have received neo\-adjuvant chemotherapy.
  • Patients with history of previous surgery of axilla or chest wall.
  • Patients with history of previous radiotherapy to the breast or axilla.
  • H/o hypersensitivity to any of the agents used.

Outcomes

Primary Outcomes

Not specified

Similar Trials